OMEROS CORP Other Non-Current Assets
OMEROS CORP (OMER) had Other Non-Current Assets of $0 as of 2016-12-31, per its 10-K filed 2017-03-16.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2017-03-16
- 2016-12-31: Other Assets, Noncurrent $0.00.
- 2016-09-30: Other Assets, Noncurrent $73.00K.
- 2016-06-30: Other Assets, Noncurrent $73.00K.
- 2016-03-31: Other Assets, Noncurrent $73.00K.
| Period end | Other Assets, Noncurrent | Other Assets, Noncurrent as first filed |
|---|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-03-16 | |
| 2016-09-30 | $73.00K 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $73.00K 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $73.00K 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $219.00K 10-K · filed 2017-03-16 | |
| 2015-09-30 | $467.00K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $488.00K 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $439.00K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $332.00K 10-K · filed 2016-03-15 | $472.00K 10-K · filed 2015-03-16 |
| 2014-09-30 | $408.00K 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $439.00K 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $267.00K 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $100.00K 10-K · filed 2015-03-16 | |
| 2013-09-30 | $113.00K 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $127.00K 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $143.00K 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $159.00K 10-K · filed 2014-03-13 | |
| 2012-09-30 | $76.00K 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $88.00K 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $102.00K 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $102.00K 10-K · filed 2013-03-18 | |
| 2011-09-30 | $119.00K 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $136.00K 10-Q · filed 2011-08-09 | |
| 2010-12-31 | $135.00K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |